$Astellas Pharma (4503.JP)$ Astellas has been approved for t...
Astellas has been approved for the treatment of age-related macular degeneration, a cause of vision loss, in the United States.
As a result, the stock price has skyrocketed, right? 😊
With age-related macular degeneration, it can damage the retina and lead to vision loss.
This new drug helps reduce that damage, really such a new drug, right? 😊
I have been really looking forward to Astellas' ophthalmology-related research and acquisitions of related companies. 😊
Moreover, eye diseases have a high demand among many people, and I think they will become closely related to daily life like lifestyle diseases in the future. 😊
Therefore, it's strong to be able to monopolize this field for a while with this new drug. 😊
I think they are likely to actively engage in shareholder returns because they can earn stable profits. 😊
I really want companies developing drugs for rare diseases to do well and I feel like cheering for them. 👍
I want to continue holding on to this for the long term. 😊
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
一日の中で重要な投資ニュースを１分で学べるように解説中。
普段はインスタグラムで節約や投資の発信をしてるので遊びにきてね
575Followers
20Following
2048Visitors
Follow